Ozempic (GLP-1 Drugs) Ozempic Blindness Lawsuit A growing number of lawsuits have been filed against the makers of Ozempic and similar drugs due to severe adverse reactions, including vision loss
Advantages over conventional drugs for targeted tissue effects Peptides tend to exhibit high specificity for their targets, which diminishes off-target effects relative to small molecules
Patients with pre-existing gastroparesis, significant gastrointestinal disease, or previous gastric surgery require particularly careful monitoring and may benefit from gastroenterology consultation before initiating GLP-1 agonist therapy
These findings align with previous reports indicating the maintenance of stem-cell-like cancer cells in established carcinoma cell lines [31]
Through research, education, and evidence-based advocacy, TOS promotes a comprehensive and science-driven approach to addressing obesity as a serious, chronic, and treatable disease